Literature DB >> 17030271

Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.

Marcus Feith1, Hubert J Stein, J Rüdiger Siewert.   

Abstract

Because of the borderline location between the esophagus and stomach, many discrepancies exist in the current literature regarding the etiology, classification, and surgical treatment of adenocarcinoma arising at the esophagogastric junction. The classification of adenocarcinomas into three types, AGE type I, type II, and type III, shows marked differences between the tumor entities and is recommended for selection of a proper surgical approach. Complete tumor resection and adequate lymphadenectomy are recommended for a good, long-term prognosis. With better surgical management and standardized procedures, even the results in patients with more radical surgical approaches, the abdomino-thoracic esophagectomy improved.

Entities:  

Mesh:

Year:  2006        PMID: 17030271     DOI: 10.1016/j.soc.2006.07.015

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  35 in total

1.  A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy.

Authors:  X Ding; J Zhang; B Li; Z Wang; W Huang; T Zhou; Y Wei; H Li
Journal:  Br J Radiol       Date:  2012-06-14       Impact factor: 3.039

2.  Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study.

Authors:  Kazumasa Fujitani; Isao Miyashiro; Shoki Mikata; Shigeyuki Tamura; Hiroshi Imamura; Johji Hara; Yukinori Kurokawa; Jyunya Fujita; Kazuhiro Nishikawa; Yutaka Kimura; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2012-08-16       Impact factor: 7.370

Review 3.  [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].

Authors:  A H Hölscher; U K Fetzner
Journal:  Chirurg       Date:  2012-08       Impact factor: 0.955

4.  Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field).

Authors:  Philippe Nafteux; Lieven Depypere; Hans Van Veer; Willy Coosemans; Toni Lerut
Journal:  Ann Cardiothorac Surg       Date:  2017-03

Review 5.  Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.

Authors:  Andrew M Brown; Danica N Giugliano; Adam C Berger; Michael J Pucci; Francesco Palazzo
Journal:  Langenbecks Arch Surg       Date:  2017-08-12       Impact factor: 3.445

6.  Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?

Authors:  Hans Fuchs; Arnulf H Hölscher; Jessica Leers; Marc Bludau; Sebastian Brinkmann; Wolfgang Schröder; Hakan Alakus; Stefan Mönig; Christian A Gutschow
Journal:  Gastric Cancer       Date:  2015-01-28       Impact factor: 7.370

7.  The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.

Authors:  Harry H Yoon; Maliha Khan; Qian Shi; Stephen D Cassivi; Tsung-Teh Wu; J Fernando Quevedo; Patrick A Burch; Frank A Sinicrope; Robert B Diasio
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

8.  The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification.

Authors:  Bala Başak Öven Ustaalioğlu; Metin Tilki; Ali Sürmelioğlu; Ahmet Bilici; Can Gönen; Recep Ustaalioğlu; Özlem Balvan; Mehmet Aliustaoğlu
Journal:  Turk J Surg       Date:  2017-03-01

9.  [Lymphadenectomy with tumors of the upper gastrointestinal tract].

Authors:  C Schuhmacher; A Novotny; K Ott; M Feith; J R Siewert
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

10.  Evolution of preoperative and postoperative therapies in the management of localized gastroesophageal cancers.

Authors:  Martin S Karpeh
Journal:  Gastrointest Cancer Res       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.